Welcome to our dedicated page for Tenet Healthcare news (Ticker: THC), a resource for investors and traders seeking the latest updates and insights on Tenet Healthcare stock.
Tenet Healthcare Corp (THC) operates a national network of hospitals and ambulatory centers, delivering acute care and technology-driven healthcare solutions. This news hub provides investors and industry professionals with timely updates on corporate developments, financial performance, and operational milestones. Stay informed about strategic initiatives shaping this diversified provider's role in the evolving healthcare sector.
Access comprehensive coverage of Tenet's press releases including earnings reports, strategic alliances, facility expansions, and regulatory updates. Our curated collection simplifies tracking the company's market position while maintaining strict editorial neutrality. Key focus areas include hospital operations, ambulatory service growth, and Conifer Health Solutions' performance.
This resource serves both casual observers and professional analysts seeking unfiltered access to primary source materials. Bookmark this page for centralized updates on Tenet Healthcare's official communications and third-party analysis. Monitor industry trends and corporate announcements affecting this leading healthcare services organization.
Tenet Healthcare reported strong Q1 2025 financial results, with net income of $406 million ($4.27 per diluted share) and Adjusted EBITDA of $1.163 billion, marking a 13.6% increase from Q1 2024. The company's Ambulatory Care segment showed impressive growth with a 15.7% increase in Adjusted EBITDA to $456 million.
Key highlights include:
- Adjusted diluted EPS increased 35.4% to $4.36
- Strong cash flow of $815 million from operations
- Same-hospital admissions grew 4.4%
- Ambulatory segment revenue increased 20%
The company's 2025 outlook projects net operating revenues between $20.6-21.0 billion and Adjusted EBITDA of $3.975-4.175 billion. Tenet maintains a strong operational position with 520 ambulatory surgery centers and 25 surgical hospitals across 37 states, demonstrating continued expansion in high-quality specialty care delivery.
Tenet Healthcare (NYSE: THC) has announced it will release its first quarter 2025 financial results before market opening on Tuesday, April 29, 2025. The company will host a conference call at 9:00 a.m. CT (10:00 a.m. Eastern Time) on the same day to discuss the results. Investors can access both a live webcast and audio archive of the earnings call through the investor relations section of Tenet's website.
Tenet Healthcare (NYSE: THC) has announced its upcoming virtual participation in the Barclays 27th Annual Global Healthcare Conference. The presentation is scheduled for Wednesday, March 12, 2024, starting at 10:00 a.m. Eastern time.
Investors and interested parties can access the live webcast and audio archive through the investor relations section of Tenet's website at www.tenethealth.com/investors. The replay will remain available for a 30-day period following the presentation.
Tenet Healthcare (NYSE: THC) reported strong Q4 2024 results with net income of $318 million ($3.32 per diluted share) and Adjusted EBITDA of $1.048 billion. The company's Ambulatory Care segment showed impressive growth with Q4 Adjusted EBITDA increasing 14.2% to $530 million.
Key financial highlights include Q4 net operating revenues of $5.072 billion, down from $5.379 billion in Q4 2023 due to hospital divestitures, offset by strong same-facility revenue growth. For full-year 2024, the company achieved net income of $3.2 billion, including a $2.916 billion pre-tax gain from hospital divestitures.
The company's 2025 outlook projects net operating revenues between $20.6-21.0 billion and Adjusted EBITDA of $3.975-4.175 billion. Tenet also reported significant deleveraging, with its net debt to Adjusted EBITDA ratio improving to 2.54x from 3.89x year-over-year.
Tenet Healthcare (NYSE: THC) has announced it will release its fourth quarter 2024 financial results before market opening on Wednesday, February 12, 2025. The company will host a conference call at 9:00 a.m. CT (10:00 a.m. ET) on the same day to discuss the results. Investors can access both the live webcast and audio archive of the call through the investor relations section of Tenet's website.
Tenet Healthcare (NYSE: THC) reported strong Q3 2024 results with net income of $472 million ($4.89 per diluted share), including a $209 million after-tax gain from hospital divestitures. Consolidated Adjusted EBITDA reached $978 million, up 14.5% year-over-year. The company's Ambulatory Care segment showed impressive growth with Adjusted EBITDA of $439 million, increasing 18.6%. Based on strong performance, Tenet raised its FY 2024 Adjusted EBITDA outlook to $3.9-4.0 billion, a $50 million increase. The company demonstrated robust cash flow generation with $2.378 billion from operating activities for the first nine months of 2024.
Tenet Healthcare (NYSE: THC) has announced its upcoming participation in the UBS Global Healthcare Conference. The presentation is scheduled for Tuesday, November 12, 2024, at 12:30 p.m. Eastern time. Investors and interested parties can access a live webcast of the presentation through Tenet's investor relations website. The presentation recording will remain available for replay on the company's website for 30 days following the event.
Tenet Healthcare (NYSE: THC) has announced it will release its third quarter 2024 financial results before the market opens on Tuesday, October 29, 2024. Following the release, the company will host a conference call at 9:00 a.m. CT (10:00 a.m. Eastern Time) to discuss the results.
Investors and interested parties can access a live webcast and audio archive of the conference call through the investor relations section of Tenet's website at www.tenethealth.com/investors. This announcement provides shareholders and analysts with a specific date to anticipate the company's latest financial performance update.
Tenet Healthcare (NYSE: THC) has completed the sale of its 70% majority ownership interest in Brookwood Baptist Health in Birmingham to Orlando Health. The transaction includes five hospitals: Brookwood Baptist Medical Center, Citizens Baptist Medical Center, Princeton Baptist Medical Center, Shelby Baptist Medical Center, and Walker Baptist Medical Center, along with other related operations.
As part of the deal, Tenet's subsidiary, Conifer Health Solutions, has entered into a ten-year contract to provide comprehensive revenue cycle management services for these operations. This sale aligns with previously disclosed terms and marks a significant change in Tenet's portfolio in the Birmingham area.
Tenet Healthcare (NYSE: THC) will present at the 2024 Wells Fargo Healthcare Conference on Wednesday, September 4, 2024, starting at 9:30 a.m. Eastern time. This event will be live webcasted and archived audio can be accessed via the investor relations section on Tenet's website, www.tenethealth.com/investors. The replay will be available for 30 days.